Details for Patent: RE37314

✉ Email this page to a colleague

Summary for Patent: RE37314

Patent landscape, scope, and claims:

Title:	Pyrimidine derivatives
Abstract:	The compounds of the present invention inhibit the HMG-CoA reductase, and subsequently suppress the biosynthesis of cholesterol. And they are useful in the treatment of hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis.
Inventor(s):	Hirai; Kentaro (Kyoto, JP), Ishiba; Teruyuki (Osaka, JP), Koike; Haruo (Kyoto, JP), Watanabe; Masamichi (Shiga, JP)
Assignee:	Shionogi Seiyaku Kabushiki Kaisha (Osaka, JP)
Application Number:	09/141,731
Patent Claim Types: see list of patent claims	Compound; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent RE37314

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: RE37314

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	3-188015	Jul 01, 1991

International Family Members for US Patent RE37314

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0521471	⤷ Subscribe	300125	Netherlands	⤷ Subscribe
European Patent Office	0521471	⤷ Subscribe	91042	Luxembourg	⤷ Subscribe
European Patent Office	0521471	⤷ Subscribe	SPC/GB03/033	United Kingdom	⤷ Subscribe
European Patent Office	0521471	⤷ Subscribe	CA 2003 00024	Denmark	⤷ Subscribe
European Patent Office	0521471	⤷ Subscribe	C00521471/01	Switzerland	⤷ Subscribe
European Patent Office	0521471	⤷ Subscribe	C300125	Netherlands	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.